Residual DNA Quantification Kit-BHK

BHK (baby hamster kidney) cells are a cell line derived from the kidneys of baby Syrian hamsters. These cells are widely used in biological and medical research due to their versatility, rapid growth, and ease of genetic manipulation. BHK cells were established in the 1960s and have since become a major model system in virology, oncology, and various other areas of cell and molecular biology. In oncology research, BHK cells are a useful model for studying cancer cell biology. These cells can be used to identify oncogenes, study mechanisms of tumorigenesis, and screen potential anticancer drugs. The ability to easily transfect BHK cells with foreign DNA allows researchers to study gene expression and regulation in a controlled environment. In addition, the adaptability of the BHK cell line to a variety of culture conditions (including serum-free media) and high transfection efficiency make it a top choice for the production of recombinant proteins and monoclonal antibodies. These cells are often used in the biopharmaceutical industry to take advantage of their rapid growth and high productivity to produce therapeutic proteins on a large scale. Residual DNA in host cells poses a potential safety concern for biopharmaceuticals as it can cause adverse immunogenic reactions or pose carcinogenic and infectious risks. Therefore, stringent guidelines and regulatory requirements require the detection and quantification of residual DNA to ensure the safety and efficacy of biopharmaceuticals. The Residual DNA Quantification Kit-BHK is a sophisticated analytical tool specifically designed to measure trace amounts of residual DNA in biopharmaceutical products, especially those derived from the BHK cell line.